HAOMA MEDICA LIMITED
Company number 06784000 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£9,151,068
Balance sheet as at 2025-01-31
What it does
Bio-tech research into a drug for the treatment of osteoporosis and osteopenia
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2009-01-06
- Employees
- 3 (2025 accounts)
- Registered office
- 14th Floor 33 Cavendish Square, London, United Kingdom, W1G 0PW
- Postcode
- W1G 0PW
- Capital
- 225,000 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-01-31
- Next due by
- 2026-10-29
- Financial year end
- 29 January
Confirmation statement
- Last statement dated
- 2026-03-19
- Next due by
- 2027-04-02
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 6 resigned
Contact details
- Website
- haomamedica.com
- Phone
- 02076291954
Haoma Medica is a UK based biotech company that focuses on treatments for Osteoporosis and Osteopenia as well as blood clotting management. The Osteoporosis & Osteopenia drug referred to as NaQuinate and commercially as Osteopura, is a novel class of compound.
Previous company names
| Name | Date changed |
|---|---|
| HAOMAMEDICA LTD | 2016-07-15 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 1 BREWERY HOUSE, BROOK STREET WIVENHOE, COLCHESTER, ESSEX, CO7 9DS | 2016-07-14 |
Among its peers
Among the oldest 25%
of 224 similar companies in W, trading since 2009
Competitors London
This company ranks 140 among research and experimental development on biotechnology in London.
The class of 2009
21%
of the 315,098 companies incorporated in 2009 are still active today; 77% have since been dissolved.
A fact about the year, not a forecast for this company.